PREVALENCE OF IODINE DEFICIENCY AMONG WOMEN OF REPRODUCTIVE AGE AND CHILDREN AGED 6-59 MONTHS IN THREE COUNTIES OF KAZAKHSTAN


Cite item

Full Text

Abstract

Iodine is one of the most important and most studied, among the many essential trace elements, the lack of which has a negative impact on human health. Kazakhstan has more than ten years' experience of universal salt iodization. In this context, the aim of this work was to evaluate the effectiveness of interventions for the prevention of iodine deficiency in sentinel populations in Akmola, East Kazakhstan (EKO) and South Kazakhstan oblasts (SKO). Methods. In cross-sectional study, which was conducted in July-August 2012 were randomly involved women of reproductive age (n = 250) and their children up to 5 years (n = 250) of Akmola, EKO (n = 256, n = 256) and SKO (n = 203, n = 203). The severity of iodine deficiency was assessed according to the criteria recommended by WHO. The content of iodine in the salt was regulated according to the normative and technical documentation of Kazakhstan. Results. Significant proportion of pregnant women in EKO 56.3 % (95 % CI: 33, 2-76, 9) and SKO 45.8 % (95 % CI: 27,9-64,9) has the level of urinary iodine below normal. Among non-pregnant women in all three studied areas there is a mild iodine deficiency, however, was detected excessive levels of iodine in 38.8 % (95 % CI: 32,2-45,7) non-pregnant women and 34.7 % (95 % CI: 28,4-41,5) children of the Akmola oblast. Determining the level of iodine in the salt consumed in the same households where urinary iodine was evaluated in women and children, to a certain extent reflects the tendency of the interdependence of consumption of iodine salt and its excretion in the urine. Discussion. In view of the situation identified as iodine deficiency and regional differences should be established for monitoring IDD urinary excretion (as high, normal, lower values). Put on a constant periodic basis the state system of monitoring the quality of iodized salt produced on all levels.

About the authors

A K Beisbekova

Казахский национальный медицинский университет имени С. Ж. Асфендиярова

Email: info@eco-vector.com

F E Ospanova

казахская академия питания

Email: info@eco-vector.com

G E Aimbetova

Казахский национальный медицинский университет имени С. Ж. Асфендиярова

Email: info@eco-vector.com

Zh T Tolysbayeva

казахская академия питания

Email: info@eco-vector.com

G Turdunova

Государственный медицинский университет г. Семей

Email: info@eco-vector.com

Sh Tokesheva

Государственный медицинский университет г. Семей

Email: info@eco-vector.com

G Amantayeva

Государственный медицинский университет г. Семей

Email: info@eco-vector.com

Zh Kalmakova

Кызылординский государственный университет имени Коркыт-Ата

Email: info@eco-vector.com

T Sh Sharmanov

Казахский национальный медицинский университет имени С. Ж. Асфендиярова; казахская академия питания

Email: info@eco-vector.com

A M Grjibovski

Норвежский институт общественного здравоохранения, Северный государственный медицинский университет, Международный казахско-турецкий университет

Author for correspondence.
Email: andrej.grjibovski@gmail.com

старший советник Норвежского института общественного здравоохранения, г. Осло, Норвегия; директор Архангельской международной школы общественного здоровья СГМУ, г. Архангельск; профессор Международного казахско-турецкого университета

Nasjonalt folkehelseinstitutt, Pb 4404 Nydalen, 0403 Oslo, Norway

References

  1. Закон Республики Казахстан «О профилактике йододефицитных заболеваний» от 14 октября 2003 года N 489, Статья 11. URL: http://online.zakon.kz/document/?doc_ id=1044558 [дата обращения: 12.11.2014]
  2. Оспанова Ф. Е. Профилактика и контроль йододефицитных заболеваний в Казахстане : автореф. дис.. д-ра биол. наук. Алматы, 2007. 27 с.
  3. Оспанова Ф. Е. Влияние комплексных мер профилактики на распространенность ЙДЗ и обеспеченность йодом // Гигиена эпидемиология и иммунобиология. 2010. № 3. C. 12-15.
  4. Цой И. Г., Оспанова Ф. Е. Йодированная соль в Казахстане. Мониторинг, контроль качества : методические рекомендации. Алматы, 2003. C. 43.
  5. A day in the life of the Araltuz salt facility: high quality iodized salt for Kazakhstan // IDD NEWSLETTER 2013. N41 P 10-12. http://lats.org/newsletter/sixty_three/ Feb2013IDDNewsletter.pdf
  6. Andersson M., Zimmerman M. B. Global iodine nutrition: a remarkable leap forward in the past decade // IDD Newsletter. 2012. N40. P. 1-5.
  7. Caldwell K., Makhmudov A., Jones R., Hollowell J. EQUIP: a world-wide program to ensure the quality of urinary iodine procedures. Accreditation and Quality Assurance // Journal for Quality, Comparability and Reliability in Chemical Measurement 2005. N 10. P 356-361
  8. ICCIDD, UNICEF, WHO. Urinary iodine. In: Assessment of Iodine Deficiency Disorders and Monitoring their Elimination // A Guide for programme managers. 2001. P 31-36.
  9. Kazakhstan triumphs over iodine deficiency // IDD NEWSLETTER 2011. N39. P. 6-7. http://www.iccidd.org/ newsletter/idd_aug11_kazakhstan.pdf
  10. Pino S., Fang S. L., Braverman L. E. Ammonium Persulfate: a safe alternative oxidizing reagent for measuring urinary iodine // Clinical Chemistry 1996. N 42. P 239-243.
  11. Qian M., Wang D., Watkins W. E., Gebski V., Yan Y. Q., Li M., Chen Z. P. The effects of iodine on intelligence in children: a meta-analysis of studies conducted in China // Asia Pac J. Clin. Nutr. 2005. N 14. P 32-42.
  12. UNICEF. Child info: Monitoring the situation of children and women. New York, United Nations Children’s Fund. Available at: www.childinfo.org (last accessed on 1 March 2012).
  13. World Health Organization and United Nations Children’s Fund. Reaching optimal iodine nutrition in pregnant and lactating women and young children. Joint statement by the World Health Organization and the United Nations Children’s Fund. Geneva: World Health Organization; 2007. http://www.who.int/nutrition/publicationsWHOStatement_ DD_pregnancy.pdf. (last accessed 19 June 2014).
  14. WHO. Global Health risks: mortality and burden of disease attributable to selected major risks. Geneva: Switzerland, WHO. 2009. Available at: http://www.who. int/healthinfo/global_burden_disease/GlobalHealthRisks_ report_full.pdf?ua=1
  15. WHO. Guideline: Fortification of food-grade salt with iodine for the prevention and control of iodine deficiency disorders. Geneva: World Health Organization; 2014. P. 44.
  16. WHO, World Food Programme, United Nations Children’s Fund. Preventing and controlling micronutrient deficiencies in populations affected by an emergency Joint statement by the World Health Organization, the World Food Programme and the United Nations Children’s Fund. Geneva: World Health Organization; 2007. http://www.who.int/ nutrition/publications (last accessed 10 September 2014).
  17. WHO Secretariat. Andersson M, de Benoist B, Delange F, Zupan J. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the technical consultation. // Public Health Nutr. 2007. N10. P. 1606-1611.
  18. Yinebeb M., Andualem M., P. N. Rajish, Getenet B. Prevalence and severity of iodine deficiency disorders among children 6-12 years of age in Shebe Senbo district, Jimma Zone, Southwest Ethiopia // Ethiop J Health Sci. 2012. N 22. P. 196-204.
  19. Zimmermann M. B. Assessing iodine status and monitoring progress of iodized salt programs // Journal of Nutrition. 2004. N 134. P. 1673-1677.
  20. Zimmerman M. B., Jooste P. L., Pandav C. S. Iodine-deficiency disorders // Lancet. 2008. N 372. P. 1251-1262.
  21. Zimmermann M. B., Andersson M. Prevalence of iodine deficiency in Europe in 2010 // Annales d’Endocrinologie. 2011. N 72. P. 164-166.

Copyright (c) 2015 Human Ecology


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies